nodes	percent_of_prediction	percent_of_DWPC	metapath
Loxapine—Dysphagia—Auranofin—psoriatic arthritis	0.0208	0.0208	CcSEcCtD
Loxapine—Menstruation irregular—Prednisolone—psoriatic arthritis	0.0191	0.0191	CcSEcCtD
Loxapine—Weight decreased—Auranofin—psoriatic arthritis	0.0189	0.0189	CcSEcCtD
Loxapine—Jaundice—Auranofin—psoriatic arthritis	0.0181	0.0181	CcSEcCtD
Loxapine—Menstruation irregular—Triamcinolone—psoriatic arthritis	0.0176	0.0176	CcSEcCtD
Loxapine—Menstruation irregular—Methylprednisolone—psoriatic arthritis	0.0176	0.0176	CcSEcCtD
Loxapine—Agranulocytosis—Auranofin—psoriatic arthritis	0.0173	0.0173	CcSEcCtD
Loxapine—Menstruation irregular—Dexamethasone—psoriatic arthritis	0.016	0.016	CcSEcCtD
Loxapine—Menstruation irregular—Betamethasone—psoriatic arthritis	0.016	0.016	CcSEcCtD
Loxapine—Alopecia—Auranofin—psoriatic arthritis	0.0147	0.0147	CcSEcCtD
Loxapine—Dysgeusia—Auranofin—psoriatic arthritis	0.0142	0.0142	CcSEcCtD
Loxapine—Glaucoma—Prednisolone—psoriatic arthritis	0.0141	0.0141	CcSEcCtD
Loxapine—Menstruation irregular—Prednisone—psoriatic arthritis	0.0139	0.0139	CcSEcCtD
Loxapine—Leukopenia—Auranofin—psoriatic arthritis	0.013	0.013	CcSEcCtD
Loxapine—Glaucoma—Triamcinolone—psoriatic arthritis	0.0129	0.0129	CcSEcCtD
Loxapine—Glaucoma—Methylprednisolone—psoriatic arthritis	0.0129	0.0129	CcSEcCtD
Loxapine—Glaucoma—Betamethasone—psoriatic arthritis	0.0117	0.0117	CcSEcCtD
Loxapine—Glaucoma—Dexamethasone—psoriatic arthritis	0.0117	0.0117	CcSEcCtD
Loxapine—Thrombocytopenia—Auranofin—psoriatic arthritis	0.0116	0.0116	CcSEcCtD
Loxapine—Amenorrhoea—Methylprednisolone—psoriatic arthritis	0.0111	0.0111	CcSEcCtD
Loxapine—Glaucoma—Prednisone—psoriatic arthritis	0.0102	0.0102	CcSEcCtD
Loxapine—Constipation—Auranofin—psoriatic arthritis	0.0101	0.0101	CcSEcCtD
Loxapine—Amenorrhoea—Dexamethasone—psoriatic arthritis	0.0101	0.0101	CcSEcCtD
Loxapine—Amenorrhoea—Betamethasone—psoriatic arthritis	0.0101	0.0101	CcSEcCtD
Loxapine—Wheezing—Triamcinolone—psoriatic arthritis	0.00946	0.00946	CcSEcCtD
Loxapine—Amenorrhoea—Prednisone—psoriatic arthritis	0.00876	0.00876	CcSEcCtD
Loxapine—Pruritus—Auranofin—psoriatic arthritis	0.00838	0.00838	CcSEcCtD
Loxapine—Dry eye—Betamethasone—psoriatic arthritis	0.00816	0.00816	CcSEcCtD
Loxapine—Dry eye—Dexamethasone—psoriatic arthritis	0.00816	0.00816	CcSEcCtD
Loxapine—Vomiting—Auranofin—psoriatic arthritis	0.00754	0.00754	CcSEcCtD
Loxapine—Rash—Auranofin—psoriatic arthritis	0.00747	0.00747	CcSEcCtD
Loxapine—Dermatitis—Auranofin—psoriatic arthritis	0.00747	0.00747	CcSEcCtD
Loxapine—Nausea—Auranofin—psoriatic arthritis	0.00704	0.00704	CcSEcCtD
Loxapine—Psychotic disorder—Methylprednisolone—psoriatic arthritis	0.00689	0.00689	CcSEcCtD
Loxapine—Dysarthria—Methotrexate—psoriatic arthritis	0.0068	0.0068	CcSEcCtD
Loxapine—Psychotic disorder—Betamethasone—psoriatic arthritis	0.00627	0.00627	CcSEcCtD
Loxapine—Psychotic disorder—Dexamethasone—psoriatic arthritis	0.00627	0.00627	CcSEcCtD
Loxapine—Weight increased—Prednisolone—psoriatic arthritis	0.00605	0.00605	CcSEcCtD
Loxapine—Bronchospasm—Methylprednisolone—psoriatic arthritis	0.006	0.006	CcSEcCtD
Loxapine—Gynaecomastia—Methotrexate—psoriatic arthritis	0.00575	0.00575	CcSEcCtD
Loxapine—Weight increased—Triamcinolone—psoriatic arthritis	0.00556	0.00556	CcSEcCtD
Loxapine—Weight increased—Methylprednisolone—psoriatic arthritis	0.00555	0.00555	CcSEcCtD
Loxapine—Psychotic disorder—Prednisone—psoriatic arthritis	0.00546	0.00546	CcSEcCtD
Loxapine—Photosensitivity—Methotrexate—psoriatic arthritis	0.00532	0.00532	CcSEcCtD
Loxapine—Weight increased—Betamethasone—psoriatic arthritis	0.00505	0.00505	CcSEcCtD
Loxapine—Weight increased—Dexamethasone—psoriatic arthritis	0.00505	0.00505	CcSEcCtD
Loxapine—Weight decreased—Dexamethasone—psoriatic arthritis	0.00502	0.00502	CcSEcCtD
Loxapine—Weight decreased—Betamethasone—psoriatic arthritis	0.00502	0.00502	CcSEcCtD
Loxapine—Cerebrovascular accident—Methotrexate—psoriatic arthritis	0.00476	0.00476	CcSEcCtD
Loxapine—Angiopathy—Methylprednisolone—psoriatic arthritis	0.00443	0.00443	CcSEcCtD
Loxapine—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.0044	0.0044	CcSEcCtD
Loxapine—Weight increased—Prednisone—psoriatic arthritis	0.00439	0.00439	CcSEcCtD
Loxapine—Weight decreased—Prednisone—psoriatic arthritis	0.00437	0.00437	CcSEcCtD
Loxapine—Vision blurred—Prednisolone—psoriatic arthritis	0.00436	0.00436	CcSEcCtD
Loxapine—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00417	0.00417	CcSEcCtD
Loxapine—Syncope—Prednisolone—psoriatic arthritis	0.00415	0.00415	CcSEcCtD
Loxapine—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00407	0.00407	CcSEcCtD
Loxapine—Angiopathy—Dexamethasone—psoriatic arthritis	0.00403	0.00403	CcSEcCtD
Loxapine—Angiopathy—Betamethasone—psoriatic arthritis	0.00403	0.00403	CcSEcCtD
Loxapine—Convulsion—Prednisolone—psoriatic arthritis	0.00401	0.00401	CcSEcCtD
Loxapine—Hypertension—Prednisolone—psoriatic arthritis	0.004	0.004	CcSEcCtD
Loxapine—Alopecia—Betamethasone—psoriatic arthritis	0.00392	0.00392	CcSEcCtD
Loxapine—Alopecia—Dexamethasone—psoriatic arthritis	0.00392	0.00392	CcSEcCtD
Loxapine—Syncope—Triamcinolone—psoriatic arthritis	0.00382	0.00382	CcSEcCtD
Loxapine—Syncope—Methylprednisolone—psoriatic arthritis	0.00381	0.00381	CcSEcCtD
Loxapine—Oedema—Prednisolone—psoriatic arthritis	0.00378	0.00378	CcSEcCtD
Loxapine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00374	0.00374	CcSEcCtD
Loxapine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00373	0.00373	CcSEcCtD
Loxapine—Shock—Prednisolone—psoriatic arthritis	0.00372	0.00372	CcSEcCtD
Loxapine—Cough—Triamcinolone—psoriatic arthritis	0.00372	0.00372	CcSEcCtD
Loxapine—Convulsion—Triamcinolone—psoriatic arthritis	0.00369	0.00369	CcSEcCtD
Loxapine—Tachycardia—Prednisolone—psoriatic arthritis	0.00369	0.00369	CcSEcCtD
Loxapine—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.00368	0.00368	CcSEcCtD
Loxapine—Convulsion—Methylprednisolone—psoriatic arthritis	0.00368	0.00368	CcSEcCtD
Loxapine—Hypertension—Triamcinolone—psoriatic arthritis	0.00368	0.00368	CcSEcCtD
Loxapine—Hypertension—Methylprednisolone—psoriatic arthritis	0.00367	0.00367	CcSEcCtD
Loxapine—Drowsiness—Methotrexate—psoriatic arthritis	0.0036	0.0036	CcSEcCtD
Loxapine—Dry mouth—Triamcinolone—psoriatic arthritis	0.00355	0.00355	CcSEcCtD
Loxapine—Renal failure—Methotrexate—psoriatic arthritis	0.00354	0.00354	CcSEcCtD
Loxapine—Angiopathy—Prednisone—psoriatic arthritis	0.00351	0.00351	CcSEcCtD
Loxapine—Confusional state—Methylprednisolone—psoriatic arthritis	0.0035	0.0035	CcSEcCtD
Loxapine—Oedema—Triamcinolone—psoriatic arthritis	0.00347	0.00347	CcSEcCtD
Loxapine—Syncope—Dexamethasone—psoriatic arthritis	0.00346	0.00346	CcSEcCtD
Loxapine—Syncope—Betamethasone—psoriatic arthritis	0.00346	0.00346	CcSEcCtD
Loxapine—Shock—Triamcinolone—psoriatic arthritis	0.00342	0.00342	CcSEcCtD
Loxapine—Insomnia—Prednisolone—psoriatic arthritis	0.00342	0.00342	CcSEcCtD
Loxapine—Alopecia—Prednisone—psoriatic arthritis	0.00342	0.00342	CcSEcCtD
Loxapine—Shock—Methylprednisolone—psoriatic arthritis	0.00341	0.00341	CcSEcCtD
Loxapine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.0034	0.0034	CcSEcCtD
Loxapine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.0034	0.0034	CcSEcCtD
Loxapine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.0034	0.0034	CcSEcCtD
Loxapine—Paraesthesia—Prednisolone—psoriatic arthritis	0.00339	0.00339	CcSEcCtD
Loxapine—Tachycardia—Triamcinolone—psoriatic arthritis	0.00339	0.00339	CcSEcCtD
Loxapine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00338	0.00338	CcSEcCtD
Loxapine—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00336	0.00336	CcSEcCtD
Loxapine—Convulsion—Dexamethasone—psoriatic arthritis	0.00335	0.00335	CcSEcCtD
Loxapine—Convulsion—Betamethasone—psoriatic arthritis	0.00335	0.00335	CcSEcCtD
Loxapine—Hypertension—Betamethasone—psoriatic arthritis	0.00334	0.00334	CcSEcCtD
Loxapine—Hypertension—Dexamethasone—psoriatic arthritis	0.00334	0.00334	CcSEcCtD
Loxapine—Hypotension—Methylprednisolone—psoriatic arthritis	0.00324	0.00324	CcSEcCtD
Loxapine—Hepatitis—Methotrexate—psoriatic arthritis	0.00323	0.00323	CcSEcCtD
Loxapine—Vision blurred—Prednisone—psoriatic arthritis	0.00317	0.00317	CcSEcCtD
Loxapine—Oedema—Dexamethasone—psoriatic arthritis	0.00315	0.00315	CcSEcCtD
Loxapine—Oedema—Betamethasone—psoriatic arthritis	0.00315	0.00315	CcSEcCtD
Loxapine—Insomnia—Triamcinolone—psoriatic arthritis	0.00314	0.00314	CcSEcCtD
Loxapine—Insomnia—Methylprednisolone—psoriatic arthritis	0.00314	0.00314	CcSEcCtD
Loxapine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00312	0.00312	CcSEcCtD
Loxapine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00311	0.00311	CcSEcCtD
Loxapine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00311	0.00311	CcSEcCtD
Loxapine—Shock—Dexamethasone—psoriatic arthritis	0.0031	0.0031	CcSEcCtD
Loxapine—Shock—Betamethasone—psoriatic arthritis	0.0031	0.0031	CcSEcCtD
Loxapine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.0031	0.0031	CcSEcCtD
Loxapine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00309	0.00309	CcSEcCtD
Loxapine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00309	0.00309	CcSEcCtD
Loxapine—Agitation—Prednisone—psoriatic arthritis	0.00309	0.00309	CcSEcCtD
Loxapine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00309	0.00309	CcSEcCtD
Loxapine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00309	0.00309	CcSEcCtD
Loxapine—Tachycardia—Dexamethasone—psoriatic arthritis	0.00308	0.00308	CcSEcCtD
Loxapine—Tachycardia—Betamethasone—psoriatic arthritis	0.00308	0.00308	CcSEcCtD
Loxapine—Syncope—Prednisone—psoriatic arthritis	0.00302	0.00302	CcSEcCtD
Loxapine—Fatigue—Triamcinolone—psoriatic arthritis	0.003	0.003	CcSEcCtD
Loxapine—Fatigue—Methylprednisolone—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Loxapine—Loss of consciousness—Prednisone—psoriatic arthritis	0.00296	0.00296	CcSEcCtD
Loxapine—Hypotension—Betamethasone—psoriatic arthritis	0.00295	0.00295	CcSEcCtD
Loxapine—Hypotension—Dexamethasone—psoriatic arthritis	0.00295	0.00295	CcSEcCtD
Loxapine—Angiopathy—Methotrexate—psoriatic arthritis	0.00293	0.00293	CcSEcCtD
Loxapine—Convulsion—Prednisone—psoriatic arthritis	0.00292	0.00292	CcSEcCtD
Loxapine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00291	0.00291	CcSEcCtD
Loxapine—Hypertension—Prednisone—psoriatic arthritis	0.0029	0.0029	CcSEcCtD
Loxapine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00286	0.00286	CcSEcCtD
Loxapine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00286	0.00286	CcSEcCtD
Loxapine—Alopecia—Methotrexate—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Loxapine—Insomnia—Betamethasone—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Loxapine—Insomnia—Dexamethasone—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Loxapine—Paraesthesia—Betamethasone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Loxapine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Loxapine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Loxapine—Dysgeusia—Methotrexate—psoriatic arthritis	0.00275	0.00275	CcSEcCtD
Loxapine—Oedema—Prednisone—psoriatic arthritis	0.00275	0.00275	CcSEcCtD
Loxapine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Loxapine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Loxapine—Fatigue—Betamethasone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Loxapine—Fatigue—Dexamethasone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Loxapine—Shock—Prednisone—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Loxapine—Nervous system disorder—Prednisone—psoriatic arthritis	0.00269	0.00269	CcSEcCtD
Loxapine—Tachycardia—Prednisone—psoriatic arthritis	0.00268	0.00268	CcSEcCtD
Loxapine—Vision blurred—Methotrexate—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Loxapine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Loxapine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Loxapine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Loxapine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00255	0.00255	CcSEcCtD
Loxapine—Leukopenia—Methotrexate—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Loxapine—Dizziness—Prednisolone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Loxapine—Asthenia—Triamcinolone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Loxapine—Asthenia—Methylprednisolone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Loxapine—Insomnia—Prednisone—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Loxapine—Paraesthesia—Prednisone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Loxapine—Pruritus—Triamcinolone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Loxapine—Cough—Methotrexate—psoriatic arthritis	0.00245	0.00245	CcSEcCtD
Loxapine—Pruritus—Methylprednisolone—psoriatic arthritis	0.00245	0.00245	CcSEcCtD
Loxapine—Convulsion—Methotrexate—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Loxapine—Chest pain—Methotrexate—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Loxapine—Rash—Prednisolone—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Loxapine—Dermatitis—Prednisolone—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Loxapine—Fatigue—Prednisone—psoriatic arthritis	0.00237	0.00237	CcSEcCtD
Loxapine—Headache—Prednisolone—psoriatic arthritis	0.00237	0.00237	CcSEcCtD
Loxapine—Constipation—Prednisone—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Loxapine—Confusional state—Methotrexate—psoriatic arthritis	0.00231	0.00231	CcSEcCtD
Loxapine—Dizziness—Triamcinolone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Loxapine—Dizziness—Methylprednisolone—psoriatic arthritis	0.00229	0.00229	CcSEcCtD
Loxapine—Feeling abnormal—Prednisone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Loxapine—Asthenia—Betamethasone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Loxapine—Asthenia—Dexamethasone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Loxapine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Loxapine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Loxapine—Nausea—Prednisolone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Loxapine—Pruritus—Dexamethasone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Loxapine—Pruritus—Betamethasone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Loxapine—Vomiting—Triamcinolone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Loxapine—Vomiting—Methylprednisolone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Loxapine—Rash—Triamcinolone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Loxapine—Dermatitis—Triamcinolone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Loxapine—Rash—Methylprednisolone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Loxapine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Loxapine—Headache—Triamcinolone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Loxapine—Headache—Methylprednisolone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Loxapine—Hypotension—Methotrexate—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Loxapine—Dizziness—Betamethasone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Loxapine—Dizziness—Dexamethasone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Loxapine—Insomnia—Methotrexate—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Loxapine—Nausea—Triamcinolone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Loxapine—Paraesthesia—Methotrexate—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Loxapine—Nausea—Methylprednisolone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Loxapine—Dyspnoea—Methotrexate—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Loxapine—Somnolence—Methotrexate—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Loxapine—Hypersensitivity—Prednisone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Loxapine—Vomiting—Betamethasone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Loxapine—Vomiting—Dexamethasone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Loxapine—Rash—Betamethasone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Loxapine—Rash—Dexamethasone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Loxapine—Dermatitis—Dexamethasone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Loxapine—Dermatitis—Betamethasone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Loxapine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Loxapine—Fatigue—Methotrexate—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Loxapine—Headache—Dexamethasone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Loxapine—Headache—Betamethasone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Loxapine—Asthenia—Prednisone—psoriatic arthritis	0.00197	0.00197	CcSEcCtD
Loxapine—Pruritus—Prednisone—psoriatic arthritis	0.00194	0.00194	CcSEcCtD
Loxapine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Loxapine—Nausea—Dexamethasone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Loxapine—Nausea—Betamethasone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Loxapine—Dizziness—Prednisone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Loxapine—Vomiting—Prednisone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Loxapine—Rash—Prednisone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Loxapine—Dermatitis—Prednisone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Loxapine—Headache—Prednisone—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Loxapine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Loxapine—Asthenia—Methotrexate—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Loxapine—Nausea—Prednisone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Loxapine—Pruritus—Methotrexate—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Loxapine—Dizziness—Methotrexate—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Loxapine—Vomiting—Methotrexate—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Loxapine—Rash—Methotrexate—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Loxapine—Dermatitis—Methotrexate—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Loxapine—Headache—Methotrexate—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Loxapine—Nausea—Methotrexate—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
